Titre : Carence en vitamine B12

Carence en vitamine B12 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lectins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Carence en vitamine B12 : Questions médicales les plus fréquentes", "headline": "Carence en vitamine B12 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Carence en vitamine B12 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-25", "dateModified": "2025-03-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Carence en vitamine B12" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carence en vitamines B", "url": "https://questionsmedicales.fr/mesh/D014804", "about": { "@type": "MedicalCondition", "name": "Carence en vitamines B", "code": { "@type": "MedicalCode", "code": "D014804", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.654.521.500.133.699" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anémie pernicieuse", "alternateName": "Anemia, Pernicious", "url": "https://questionsmedicales.fr/mesh/D000752", "about": { "@type": "MedicalCondition", "name": "Anémie pernicieuse", "code": { "@type": "MedicalCode", "code": "D000752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.654.521.500.133.699.923.280" } } } ], "about": { "@type": "MedicalCondition", "name": "Carence en vitamine B12", "alternateName": "Vitamin B 12 Deficiency", "code": { "@type": "MedicalCode", "code": "D014806", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dorota Gryko", "url": "https://questionsmedicales.fr/author/Dorota%20Gryko", "affiliation": { "@type": "Organization", "name": "Institute of Organic Chemistry, Polish Academy of Sciences, Warsaw, Poland. dorota.gryko@icho.edu.pl." } }, { "@type": "Person", "name": "Jacob Selhub", "url": "https://questionsmedicales.fr/author/Jacob%20Selhub", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Setareh Shahab-Ferdows", "url": "https://questionsmedicales.fr/author/Setareh%20Shahab-Ferdows", "affiliation": { "@type": "Organization", "name": "Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA, United States." } }, { "@type": "Person", "name": "Daniela Hampel", "url": "https://questionsmedicales.fr/author/Daniela%20Hampel", "affiliation": { "@type": "Organization", "name": "Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA, United States; Department of Nutrition, University of California, Davis, CA, United States." } }, { "@type": "Person", "name": "Lindsay H Allen", "url": "https://questionsmedicales.fr/author/Lindsay%20H%20Allen", "affiliation": { "@type": "Organization", "name": "Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36120492", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bbrep.2022.101341" } }, { "@type": "ScholarlyArticle", "name": "Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35804351", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12933-022-01562-0" } }, { "@type": "ScholarlyArticle", "name": "A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.", "datePublished": "2024-08-17", "url": "https://questionsmedicales.fr/article/39211151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/2024.08.15.608041" } }, { "@type": "ScholarlyArticle", "name": "A combination of the HLA-DRB1*03 phenotype and low plasma mannose-binding lectin predisposes to autoantibody formation in women with recurrent pregnancy loss.", "datePublished": "2023-01-26", "url": "https://questionsmedicales.fr/article/36776871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1069974" } }, { "@type": "ScholarlyArticle", "name": "Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis.", "datePublished": "2023-08-31", "url": "https://questionsmedicales.fr/article/37720512", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmed.2023.1228636" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies métaboliques et nutritionnelles", "item": "https://questionsmedicales.fr/mesh/D009750" }, { "@type": "ListItem", "position": 3, "name": "Troubles nutritionnels", "item": "https://questionsmedicales.fr/mesh/D009748" }, { "@type": "ListItem", "position": 4, "name": "Malnutrition", "item": "https://questionsmedicales.fr/mesh/D044342" }, { "@type": "ListItem", "position": 5, "name": "Maladies de carence", "item": "https://questionsmedicales.fr/mesh/D003677" }, { "@type": "ListItem", "position": 6, "name": "Avitaminoses", "item": "https://questionsmedicales.fr/mesh/D001361" }, { "@type": "ListItem", "position": 7, "name": "Carence en vitamines B", "item": "https://questionsmedicales.fr/mesh/D014804" }, { "@type": "ListItem", "position": 8, "name": "Carence en vitamine B12", "item": "https://questionsmedicales.fr/mesh/D014806" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Carence en vitamine B12 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Carence en vitamine B12", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Carence en vitamine B12", "description": "Comment diagnostiquer une carence en vitamine B12 ?\nQuels tests sont utilisés pour confirmer la carence ?\nQuels signes cliniques indiquent une carence ?\nLa carence en B12 peut-elle être asymptomatique ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014806?mesh_terms=Lectins&page=58#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Carence en vitamine B12", "description": "Quels sont les symptômes courants de la carence en B12 ?\nLa carence en B12 peut-elle causer des problèmes neurologiques ?\nComment la carence affecte-t-elle la peau ?\nY a-t-il des symptômes digestifs associés ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D014806?mesh_terms=Lectins&page=58#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Carence en vitamine B12", "description": "Comment prévenir la carence en vitamine B12 ?\nLes personnes âgées doivent-elles prendre des suppléments ?\nLes végétaliens peuvent-ils éviter la carence ?\nLes tests réguliers sont-ils recommandés ?\nLes maladies digestives augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D014806?mesh_terms=Lectins&page=58#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Carence en vitamine B12", "description": "Comment traiter une carence en vitamine B12 ?\nQuelle est la durée du traitement ?\nLes aliments peuvent-ils aider à corriger la carence ?\nLes personnes végétariennes sont-elles à risque ?\nLes traitements sont-ils différents pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D014806?mesh_terms=Lectins&page=58#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Carence en vitamine B12", "description": "Quelles complications peuvent survenir ?\nLa carence peut-elle entraîner des problèmes cognitifs ?\nY a-t-il un risque accru de maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?\nLa carence en B12 peut-elle affecter la grossesse ?", "url": "https://questionsmedicales.fr/mesh/D014806?mesh_terms=Lectins&page=58#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Carence en vitamine B12", "description": "Qui est le plus à risque de carence en B12 ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLes médicaments peuvent-ils influencer le risque ?\nLes troubles digestifs sont-ils un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D014806?mesh_terms=Lectins&page=58#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en vitamine B12 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des analyses sanguines mesurant les niveaux de vitamine B12." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer la carence ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la mesure de la vitamine B12, de l'homocystéine et de la méthylmalonyl-CoA." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une carence ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'anémie, la fatigue, et des troubles neurologiques peuvent indiquer une carence." } }, { "@type": "Question", "name": "La carence en B12 peut-elle être asymptomatique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent avoir une carence sans présenter de symptômes visibles." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des facteurs de risque comme des troubles d'absorption." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la carence en B12 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, faiblesse, engourdissements et troubles de l'humeur." } }, { "@type": "Question", "name": "La carence en B12 peut-elle causer des problèmes neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des troubles neurologiques comme des démences ou des neuropathies." } }, { "@type": "Question", "name": "Comment la carence affecte-t-elle la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des changements cutanés comme une pâleur ou des lésions cutanées." } }, { "@type": "Question", "name": "Y a-t-il des symptômes digestifs associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des nausées, des diarrhées ou des troubles digestifs peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de l'absorption réduite." } }, { "@type": "Question", "name": "Comment prévenir la carence en vitamine B12 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée incluant des sources de B12 et des suppléments si nécessaire aide." } }, { "@type": "Question", "name": "Les personnes âgées doivent-elles prendre des suppléments ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir besoin de suppléments en raison d'une absorption réduite." } }, { "@type": "Question", "name": "Les végétaliens peuvent-ils éviter la carence ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Ils doivent prendre des suppléments de B12 ou consommer des aliments enrichis pour éviter la carence." } }, { "@type": "Question", "name": "Les tests réguliers sont-ils recommandés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests réguliers sont conseillés pour les personnes à risque de carence." } }, { "@type": "Question", "name": "Les maladies digestives augmentent-elles le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la maladie de Crohn peuvent affecter l'absorption de la vitamine B12." } }, { "@type": "Question", "name": "Comment traiter une carence en vitamine B12 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des suppléments oraux ou des injections de vitamine B12 selon la gravité." } }, { "@type": "Question", "name": "Quelle est la durée du traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La durée dépend de la gravité, mais peut durer de quelques mois à plusieurs années." } }, { "@type": "Question", "name": "Les aliments peuvent-ils aider à corriger la carence ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, consommer des aliments riches en B12 comme la viande, le poisson et les produits laitiers aide." } }, { "@type": "Question", "name": "Les personnes végétariennes sont-elles à risque ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être à risque en raison d'un apport alimentaire limité en vitamine B12." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements sont similaires, mais les doses peuvent varier selon l'âge et le poids." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'anémie mégaloblastique, des troubles neurologiques et des problèmes cardiaques." } }, { "@type": "Question", "name": "La carence peut-elle entraîner des problèmes cognitifs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence prolongée peut causer des troubles cognitifs et des pertes de mémoire." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de maladies cardiovasculaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence en B12 peut augmenter le risque de maladies cardiovasculaires en élevant l'homocystéine." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "La carence en B12 peut-elle affecter la grossesse ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des complications pendant la grossesse, comme des malformations congénitales." } }, { "@type": "Question", "name": "Qui est le plus à risque de carence en B12 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, les végétariens, et ceux ayant des troubles d'absorption sont à risque." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la gastrite atrophique peuvent affecter l'absorption de la B12." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments comme les inhibiteurs de la pompe à protons peuvent réduire l'absorption." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme la maladie cœliaque peuvent nuire à l'absorption de la vitamine B12." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de carence peuvent augmenter le risque chez certains individus." } } ] } ] }

Sources (623 au total)

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.

Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine wh... MBL levels were assessed at discharge and after 3 months in 161 AMI patients without any previously known glucose perturbations and in 183 age- and gender-matched controls from the Glucose metabolism ... At hospital discharge patients had higher MBL levels (median 1246 μg/L) than three months later (median 575 μg/L; p < 0.01), the latter did not significantly differ from those in the controls (801 μg/... Patients had higher MBL levels than controls during the hospital phase of AMI, supporting the assumption that elevated MBL reflects acute stress. MBL was not found to be independently associated with ...

A combination of the HLA-DRB1*03 phenotype and low plasma mannose-binding lectin predisposes to autoantibody formation in women with recurrent pregnancy loss.

It is documented that a series of autoantibodies can be detected with increased frequency in women with recurrent pregnancy loss (RPL) and they may impact the pregnancy prognosis negatively. It is unk... In 663 patients with RPL in whom we had results for HLA-DRB1 typing and plasma mannose-binding lectin (p-MBL) measurement, it was investigated whether there is a correlation between positivity for the... Although slightly higher frequencies of positivity of two or more autoantibodies were seen in patients with either p-MBL ≤500 µg/l or being positive for HLA-DRB1*03, none were significantly associated... In conclusion, to clarify the pathogenetic background, underlying immunogenetic factors should be examined in autoantibody positive RPL patients (as well as other patients with autoimmune diseases) bu...

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis.

Hepatitis B virus (HBV) infection is the most common cause of liver cirrhosis. Portal venous system thrombosis (PVST) is a major complication of liver cirrhosis. Recently, it has been shown that C-typ... Overall, 65 patients with HBV-related liver cirrhosis were included, of whom 23 had PVST and 42 did not have. Serum CLEC-2 and galectin-1 levels were measured using enzyme-linked immunosorbent assay k... Patients with PVST had significantly higher serum CLEC-2 (... Serum CLEC-2 and galectin-1 levels may be associated with the presence of PVST in HBV-related cirrhotic patients, but this association should be dependent upon the degree of PVST....

C-type lectin-like receptor-2 in platelets mediates ferric chloride-induced platelet activation and attenuates ferroptosis of endothelial cells.

An iron overload status induces ferroptosis, an iron-dependent nonapoptotic cell death, in various pathological conditions. We previously reported that hemin (heme), protoporphyrin-IX with ferric iron... This study aimed to elucidate platelet activation mechanisms of iron (ferric chloride), including the identification of signaling pathways and receptors, and to examine whether platelets regulate ferr... Platelet aggregometry, platelet activation marker expression, and protein phosphorylation were examined in ferric chloride-stimulated human and murine platelets. Inhibitors of platelet activation sign... Ferric chloride induced platelet activation dependent on Src family kinase pathways in humans and mice. Ferric chloride-induced platelet aggregation was almost lost in CLEC-2-depleted murine platelets... Ferric chloride activates platelets via CLEC-2 and Src family kinase pathways, and platelets have a protective role in the ferroptosis of endothelial cells dependent on CLEC-2....